APA (7th ed.) Citation

AE, C., V, P., P, I., KA, T., D, T., A, D., . . . AG, T. (2026). Reply to the comment on: "Dalbavancin for infective endocarditis: a systematic review of effectiveness, safety, and dosing". European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. https://doi.org/10.1007/s10096-026-05597-z

Chicago Style (17th ed.) Citation

AE, Chaldoupis, et al. "Reply to the Comment on: "Dalbavancin for Infective Endocarditis: A Systematic Review of Effectiveness, Safety, and Dosing"." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology 2026. https://doi.org/10.1007/s10096-026-05597-z.

MLA (9th ed.) Citation

AE, Chaldoupis, et al. "Reply to the Comment on: "Dalbavancin for Infective Endocarditis: A Systematic Review of Effectiveness, Safety, and Dosing"." European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology, 2026, https://doi.org/10.1007/s10096-026-05597-z.